In the context of Lesch-Nyhan syndrome, iPSC-derived neural models, including neural organoids, could serve as innovative platforms for studying the effects of HPRT1 variants and evaluating potential therapies. This evidence concerns the gene HPRT1 and Lesch-Nyhan syndrome.